Dr Anna Becker originally founded Endotech in 2012; she personally leads both our trading software development and operating teams herself. A key global technology influencer and well-known specialist in the fintech market, her history includes over a billion dollars of assets under management (AUM) and her systems have been used to manage institutional equity for over a decade. From market analysts, to quant data units, more than half of the EndoTech team holds PhD level qualification in a spectrum of different sciences. Regarded as the backbone of the AI/ML fintech market, Endotech and the proprietary systems that Dr Anna Becker has created are currently being used at more than 150 private financial institutions globally. In January 2020 Dr. Becker and our senior founding partners created and launched ETBOT.io with the aim of providing genuine Hedge Fund results for the global online retail trader market. New traders and complete beginners are most at risk when investing into the market. ETBOT provides a safe method of entry and engagement for beginner funds, no advanced knowledge is required. Retail traders who are seeking higher or more stable returns will be able to easily assign a portion or total amount of their rolling funds and portfolio, connecting themselves to market proven trading results and returns. Large scale Retail investors and networks, corporate entities, publicly listed companies, Hedge Funds and family offices may apply for our services within our Institutional area via https://endotech.io

Main info

Hosting info

Payment systems

Payment systems available 

Withdraw types

Ratings and monitors

Remarks